The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Lipoprotein A, Lp (a), Lp(a)
Also known as: Ion Mobility, Cardio IQ Lipoprotein Fractionation, Ion Mobility , HDL Subfractions, IDL Subfractions, LDL Subfractions, Lipoprotein Fraction, Lipoprotein Fractionation, Lipoprotein Fractionation Ion Mobility Cardio IQ, Quest Diagnostics has replaced the VAP® Cholesterol Test with Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ test
The Healthy Blood Vessels - The Advanced Lipid Panel with Lp(a) panel contains 4 tests with 15 biomarkers.
Brief Description: The Healthy Blood Vessels - The Advanced Lipid Panel with Lp(a) is a comprehensive diagnostic tool designed to provide an in-depth assessment of cardiovascular risk based on lipid profile and specific markers associated with cardiovascular diseases. This panel includes tests for Apolipoprotein B, Lipoprotein (a), a traditional Lipid Panel with Ratios, and Lipoprotein Fractionation Ion Mobility. By evaluating these specific biomarkers, the panel offers a nuanced view of lipid metabolism and its implications for heart health, beyond what a standard lipid panel provides.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Fasting for 12 hours is required.
This panel may be ordered for individuals with a family history of heart disease, those with existing cardiovascular conditions, or when traditional lipid panels suggest elevated risk. It's also recommended for those with risk factors such as hypertension, diabetes, smoking, obesity, or a sedentary lifestyle. The advanced insights provided by this panel assist in refining risk assessment and tailoring more effective prevention and treatment strategies for cardiovascular diseases.
ApoB is the primary protein component of LDL cholesterol and VLDL particles. High levels of ApoB indicate a greater number of atherogenic particles, contributing to plaque buildup in arteries.
Lp(a) is a variant of LDL cholesterol with an additional protein that makes it more likely to cause inflammation and clotting. Elevated Lp(a) levels are considered a significant risk factor for cardiovascular diseases.
This test measures total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides, providing ratios of these lipids that help assess cardiovascular risk.
Lipoprotein Fractionation Ion Mobility
This advanced technique separates lipoproteins by size and density, offering detailed information on the distribution of lipid particles, including small, dense LDL particles that are more atherogenic.
Cardiovascular Disease
The panel's comprehensive assessment identifies individuals at increased risk for coronary artery disease, stroke, and peripheral artery disease by highlighting elevated levels of atherogenic lipoproteins.
Atherosclerosis
By detecting elevated levels of ApoB, Lp(a), and small, dense LDL particles, the panel can identify individuals at risk for atherosclerosis, characterized by plaque buildup in the arteries.
Cardiovascular Disease
Providers can use the detailed information from the panel to personalize treatment plans, including lifestyle changes, statin therapy, and other medications to manage lipid levels and reduce cardiovascular risk.
Atherosclerosis
The detection of specific lipid abnormalities enables targeted interventions to slow plaque buildup, such as dietary modifications, increased physical activity, and possibly the use of niacin or fibrates to improve lipid particle profiles.
The Healthy Blood Vessels - The Advanced Lipid Panel with Lp(a) offers a sophisticated evaluation of cardiovascular risk, providing valuable insights that go beyond traditional lipid measurements. By identifying key risk factors for cardiovascular disease and atherosclerosis, this panel enables healthcare professionals to implement precise and effective strategies for prevention, monitoring, and treatment. Utilizing this advanced panel supports a proactive approach to cardiovascular health, aiming to mitigate risk and improve long-term outcomes for individuals at risk of heart disease.